Entropic Biosciences is a UCLA-spun biotechnology company developing proprietary biological tooling and organoid platforms that address critical limitations in current in vitro model systems, including low throughput and slow physiological maturation. The company leverages its core material technology, Twister™, to enable rapid formation of complex 3D bilayer tissues with enhanced viability, physiological relevance, and scalability.
